HOPO Therapeutics is a clinical-stage pharmaceutical company leveraging its world-class expertise to develop treatments for heavy metal poisoning and to pioneer novel methods for directed radioisotope delivery. The company’s orally-available flagship drug candidate HOPO-101 is a heavy metal chelating agent positioned to become the best-in-class solution for significant unmet needs in lead poisoning and other forms of heavy metal toxicity, as well as nuclear and radiological threat readiness. HOPO-101 has been well-tolerated in an ongoing Phase 1 safety study, and has shown superior pre-clinical efficacy compared to the standard-of-care medical countermeasure. Further development of this chelating agent into a delivery platform for radioisotopes has yielded pipeline drug candidates with class-leading properties for targeted PET imaging and radioligand therapy.
External link for HOPO Therapeutics
San Francisco Bay Area, US
HOPO Therapeutics reposted this
The nation must stay ready for public health emergencies, including radiological incidents and toxic heavy metal exposures. That’s why we’re partnering with HOPO Therapeutics to advance development of HOPO-101, an easy-to-administer oral decorporation agent intended to treat internal contamination from radionuclides (radioactive forms of elements) and toxic heavy metals. Learn more about this partnership and other opportunities: https://ow.ly/WIhP50TSuKy
We are delighted to announce that we have been awarded an R&D contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, of up to $226 million for the advancement of our orally-available chelating agent HOPO-101 for treatment of internalized radionuclides and toxic heavy metal exposure. This partnership will accelerate our efforts to fill an important gap in preparedness for nuclear threats, while also seeking to develop a treatment for lead poisoning, one of the most significant unmet needs in global health. https://lnkd.in/gmg9TFUH
We're excited to work with Umaro Foods! Interested in joining us? We're hiring! Take a look at www.hopotx.com/jobs for open research positions on our team.
Bakar Labs tenants #Umaro and HOPO Therapeutics have joined forces in an innovative partnership to extract rare earth elements from seaweed. Is that cool or what? Traditional methods of extracting rare earth elements often involve environmentally destructive mining. Umaro and HOPO are pioneering a #sustainable alternative by harnessing the rich mineral content of seaweed, avoiding the ecological impact of traditional mining practices. It's good for the planet, and good for the economy, too! Learn more here: https://lnkd.in/gn5T6b-C Beth Zotter Amanda Stiles Julian Rees Hannah Weber